to make an early diagnosis of cervical pregnancy, various conservative surgical techniques, such as cervical curettage The case reports of 22 patients with cervical pregnancies followed by intracervical balloon tamponade or cervical treated by methotrexate (MTX) administration and pubcerclage, angio-embolization of feeding arteries and bilateral lished in English literature between 1983 and 1995 were ligation of hypogastric arteries, could be performed in an effort reviewed, by either original paper review or follow-up to avoid total hysterectomy and preserve fertility potential under international collaboration, to determine the sub- (Bachus et al., 1990; Frates et al., 1994 ; Meerssche et al., sequent reproductive performance and obstetric outcomes.
1995). The more conservative method of methotrexate (MTX) Out of 22 cases, 18 (78%) MTX chemotherapy attempts
administration, a non-surgical and minimally invasive approach succeeded with complete remission and four (22%) failed.
to eradicate trophoblasts within the endocervix, is now a Of the 13 women who wished to conceive and could be viable treatment option. Meerssche et al. (1995) proposed an followed for at least 3 years, nine succeeded in having live algorithm for the management of cervical pregnancy of Ͻ12 births without congenital malformations, one spongestational weeks. There were two arms in the algorithm. One taneously aborted and three suffered infertility. In general, underwent surgical curettage followed by a cervical tamponing MTX chemotherapy alone or combined with adjuvant technique, and the other received MTX therapy. MTX therapy methods such as subsequent cervical curettage or cervical in combination with high-resolution ultrasound and rapid tamponade, or intracervical potassium chloride injection, quantification of serum human chorionic gonadotrophin is a appears to be a convenient and effective method for the milestone in the shift in treatment modality away from surgical treatment of the majority of cervical pregnancies before approaches toward non-invasive therapy. MTX therapy may 12 weeks gestation, and has not been shown to have provide a favourable prognosis and is rapidly becoming the detrimental effects on subsequent reproductive capacities, method of choice in the majority of cases of cervical pregnancy. obstetric outcomes and progeny health for those cases with
The main concern expressed by patients of childbearing age successful preservation of the uteri.
after MTX treatment for cervical pregnancy is for their Key words: cervical pregnancy/methotrexate/reproduction prospects of a successful pregnancy in the future. Here we examine the subsequent reproductive performance, obstetric outcomes and birth health of patients with a prior cervical Introduction pregnancy treated by MTX alone or in combination with adjuvant procedures. The main purposes of this study were to Cervical pregnancy, a rare form of ectopic pregnancy, results from the passage of a blastocyst through the uterine cavity and determine the efficiency of chemotherapy with MTX in treating cervical pregnancy and maintenance of fertility potential, its subsequent implantation and growth within the endocervical canal. Cervical pregnancy is extremely difficult to manage and and to provide reassurance of the normality of the children subsequently born to mothers receiving MTX therapy. generally results in either spontaneous abortion or a surgical attempt at evacuation, both of which might be combined with life-threatening bleeding. Before 1979, the occurrence of cervical pregnancy made most women sterile because an Materials and methods unavoidable hysterectomy to save the life of the patient was Case reports of cervical pregnancy treated by MTX, which had been mandatory in~90% of cases (Bachus et al., 1990) . After published in English literature during the period 1983-1995 and could the advent of ultrasound, ultrasonic criteria were developed be retrieved using the CD-PLUS MEDLINE OVID system (OVID Technologies Inc., NY, USA), were screened for this international (Raskin, 1978; Hofmann et al., 1987) Of the 19 women whose uteri were preserved following treatment modality. Factors that were considered in assessing the treatment, 18 indicated the desire to conceive in the future reproductive status of the patients after cervical pregnancy included after cervical pregnancies, while one woman was undecided the desire for pregnancy, the diagnosis of infertility, the obstetric (Miyamura et al., 1993) . Only 16 of these patients were outcome of the first conception following the cervical pregnancy, the followed for at least 3 years after their cervical pregnancy.
mode of delivery and the presence or absence of birth defects in the Among the 16 women who received follow-up, two did not live-born children. Those case reports that totally or partially lacked want to conceive yet (Timor-Tritsch et al., 1994) , one conceived information on subsequent gestations were supplemented by direct correspondence with the authors, who were requested to complete a despite not wanting a pregnancy and received an elective questionnaire. Cases were excluded from the study if an adequate termination (Palti et al., 1989) al., 1995; Mantalenakis et al., 1995; Zohav et al., 1995) ,
one term twin (Timor-Tritsch et al., 1994) , one live twin and one preterm healthy delivery (Bakri Results and Badawi, 1990) . One patient spontaneously aborted at 8 weeks of gestation (Yankowitz et al., 1990) , and the remaining Our literature search produced a total of 37 case reports of patients with cervical pregnancies whose management included three patients suffered infertility (Balasch et al., 1994; Frates et al., 1994) and failed to conceive even after an attempt at MTX chemotherapy, reported in 26 publications. Eight of these case reports contained information regarding subsequent in-vitro fertilization in one case . Neither repetitive cervical pregnancy nor other forms of ectopic reproductive function and obstetric outcomes (Farabow et al., 1983; Cheng et al., 1986; Wolcott et al., 1988; Bakri and pregnancy occurred. Concerning the obstetric management and outcomes of the Badawi, 1990; Yankowitz et al., 1990; Dall et al., 1994; Mantalenakis et al., 1995; Zohav et al., 1995) . In the remaining nine wanted pregnancies which were carried to live births, four deliveries were via the vaginal route, four were via 29 cases, which had incomplete information on subsequent reproductive function and obstetric outcomes (in 18 separate Caesarean section and another one was unknown. No patient was found to have cervical incompetence during pregnancy, reports), questionnaires were sent to the 18 corresponding authors by registered mail. A total of nine questionnaire although a singleton preterm delivery occurred at 32 weeks gestation (Bakri and Badawi, 1990) . None of the infants was responses were obtained. Analysis of the questionnaire data showed that 14 cervical pregnancy cases met our study criteria.
found to have either minor or major anomalies or neonatal morbidity or mortality. One case of placenta increta (Kim Thus, a total of 22 (the original eight plus 14) cases, which could be traced from the diagnosis of cervical pregnancy to et al., 1989) requiring a Caesarean hysterectomy occurred among the nine deliveries. subsequent gestation after cervical pregnancy, formed the study database. Table I lists the patient characteristics, concomitant The therapeutic doses and protocols of MTX administration varied with the reports. Generally speaking, a schedule of 0.5-therapeutic procedures and reproductive and obstetric outcomes in detail.
1.0 mg/kg every other day for 5-7 days with folinic acid rescue i.m. (Farabow et al., 1983; Kim et al., 1989 ; Palti et al., Of 22 MTX treatments with or without other concomitant procedures, 18 (78%) succeeded in complete remission and 1989; Yankowitz et al., 1990; Roussis et al., 1992; Balasch et al., 1994; Kung et al., 1995) and/or a single injection of four (22%) treatments failed. Among the 18 patients with complete remission, six (whose pregnancies had gestational 12.5-50.0 mg intracervically or intra-amniotically (TimorTritsch et al., 1994; Mantalenakis et al., 1995) was commonly ages varying between 6 weeks and 8 weeks 4 days) received MTX administration only and the other 12 required concomitused. The route of MTX administration was systemic and/or intra-amniotic injection or a combination of the two, depending ant adjuvant therapeutic procedures either during or after MTX treatment (Table I ). The concomitant procedures for those 12 on the choice of the investigator. However, there was a significant clinical implication that MTX treatment appeared patients included cervical curettage in five cases, intra-amniotic potassium chloride injection in two cases, vaginal packing in to be more effective and convenient if MTX was administered locally through intracervical or intra-amniotic injection under one case, the combination of dilatation and curettage and tamponade in one case, embolization of the uterine artery in initial ultrasonic guidance, with or without a subsequent sequential systemic injection for those cases of a viable cervical one case, the combination of embolization and dilatation and evacuation in one case and simultaneous chemotherapy with pregnancy with fetal cardiac activity (Palti et al., 1989; TimorTritsch et al., 1994; Mantalenakis et al., 1995) . actinomycin D and cyclophosphamide in one case. Among the four patients whose MTX attempts failed, three lost reproduct-
The mean time interval between elimination of the cervical pregnancy by MTX and the awareness of subsequent concepive function because of the need for a hysterectomy (Farabow et al., 1983; Cheng et al., 1986; Dall et al., 1994) and one tion was 8 months, as averaged from the sum of five available data sources, including 8 months from Yankowitz et al. (1990) , non-viable cervical pregnancies. However, after trophoblast 10 months from Bakri and Badawi (1990) , 12 months from shedding, either spontaneously or manually, rapid and massive Zohav et al. (1994) , 5 months from Mantalenakis et al. (1995) bleeding from the uninvolutional and atonic cervix could occur and 6 months from Kung et al. (1995) .
unexpectedly. Failure of MTX therapy occurred in four patients. One MTX, a cytotoxic drug, has been thought to have a potential failure occurred at 20 weeks gestation (Farabow et al., 1983) , mutagenic activity on animal and human gametes and also one at 12 weeks gestation (Wolcott et al., 1988) and the other teratogenic effects on concepti. Out of a total of 11 posttwo at 9 weeks gestation (Cheng et al., 1986; Dall et al., cervical pregnancy concepti in this study, nine developed to 1994). The first patient eventually underwent hysterectomy live births without any congenital defects, one ended in elective during the second laparotomy because of an unresectable abortion because of an unwanted intrauterine pregnancy and cervical mass, which was misdiagnosed as malignant gestaone (9%) had a spontaneous abortion of unknown cause at tional trophoblastic disease unresponsive to chemotherapy. The 9 weeks gestation. According to this observation, patients second patient had successful preservation of the uterus after experiencing MTX administration are not likely to be at a major operation with a combination of iliac artery ligation, increased risk of fetal anomalies or spontaneous abortion in hysterotomy and intracervical balloon tamponade following later conceptions. Actually, total doses of MTX used during failure of the initial management with MTX. The remaining the entire treatment course of cervical pregnancy were not two patients both required an emergency hysterectomy because high when compared with those used for treating gestational of uncontrollable bleeding from the cervix. The uncontrollable trophoblastic tumours (Rustin et al., 1984) . Furthermore, on bleeding occurred during evacuation and curettage in the third the basis of previous data on patients with unruptured tubal patient and at follow-up after the completion of MTX therapy pregnancies, MTX therapy, when compared with salpingin the fourth patient.
ostomy via laparoscopy or laparotomy, has not impaired subsequent reproductive performance (Stovall et al., 1990; Pansk et al., 1993; Darai et al., 1996) . MTX was administered Discussion in a sequential way or via a single injection. The relatively Previously, reports of patients with cervical pregnancies treated low dose and short exposure duration of MTX minimize its with MTX were mostly considered as case reports because of potential systemic side-effects and any possible hazardous their rarity with an incidence ranging from 1 in 2400 to 1 in inducement of follicular growth in the ovaries. 50 000 pregnancies (Parente et al., 1983 ). This made difficult
The possible loss of adequate anatomical patency and an adequate overall assessment of the efficacy of MTX hospitable mucus production of the cervix, resulting from therapy and an evaluation of subsequent reproductive potential trophoblast invasion and its sequelae after eradication, may be following cervical pregnancy. This retrospective study has used implicated in disruption in the outflow of resumptive menses international cooperation to follow and describe reproductive and transport of spermatozoa in the reproductive tract. Howperformance and the perinatal outcome of the first conception ever, results from this study indicated that a combination of after MTX treatment of cervical pregnancy during the period return of normal menstruation in all patients and achievement from 1983, when Farabow et al. (1983) introduced MTX of 11 intrauterine pregnancies among 14 patients who either treatment of cervical pregnancy, to 1995. The preliminary wished to conceive (13 cases) or had an unwanted conception result of this study reveals a significant chemotherapeutic (one case) showed that cervical function was restored without effectiveness of MTX therapy alone or in combination with impairment. Balasch et al. (1994) performed hysteroscopies adjuvant therapy, and an apparent lack of detrimental effects to examine the cervix and found the endocervical canal to be on subsequent reproductive function and pregnancy outcomes normal 1 week after complete eradication of the trophoblasts. in patients after MTX treatment of cervical pregnancy with a Thus, it appears that when a sufficient portion of the cervix is gestational age younger than the first trimester.
preserved, cervical function is more likely to recover. On the Successful MTX therapy was achieved in 18 out of 22 basis of follow-up data available on five pregnancies, the mean cases. However, 12 cases required the use of adjuvant therapies time interval between elimination of disease and diagnosis of in addition to MTX administration. MTX therapy can be a subsequent conception was 8 months, with the shortest period good treatment choice for cervical pregnancy, and combination being 5 months. We suggest a minimum 8 month followwith less invasive surgical procedures is mandatory under up period before attempting subsequent pregnancy following some circumstances. In patients with a viable cervical pregcervical pregnancy so as to ensure adequate functional recovery nancy, initial intra-amniotic injection of MTX to cease fetal of the cervix. cardiac activity was more effective than systemic MTX The incidence of infertility after MTX treatment for cervical administration only, and would be likely to minimize the pregnancy, excluding those patients receiving a hysterectomy, potential risk of MTX treatment failure.
was 23% (three out of 13 who wished to conceive). Actually, Four attempts at MTX treatment failed. A total hysterectomy infertility problems had been anticipated in all three cases to remove the entire uterus and the diseased cervix was before the cervical pregnancy occurred. On the basis of this required in two patients because uncontrollable haemorrhaging result, we might speculate that a prior cervical pregnancy occurred. In our opinion, MTX, via either systemic or local with MTX treatment does not impair subsequent reproductive administration, effectively destroyed the aberrant trophoblasts within the endocervical canal in those patients who had function and that the risk of infertility after MTX therapy does not generally increase. However, a larger study population will In conclusion, the MTX regimen has been shown to be Pansky, M., Bukovsky, I., Golan, A. et al. (1993) 
